Literature DB >> 27930839

Expanding the Klebsiella pneumoniae volatile metabolome using advanced analytical instrumentation for the detection of novel metabolites.

C A Rees1, F A Franchina2, K V Nordick3, P J Kim3, J E Hill1,2.   

Abstract

AIMS: The purpose of this study was to identify the volatile molecules produced by the pathogenic Gram-negative bacterium Klebsiella pneumoniae (ATCC 13883) during in vitro growth using comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry (GC×GC-TOFMS). METHODS AND
RESULTS: Klebsiella pneumoniae ATCC 13883 was incubated in lysogeny broth to mid-exponential and stationary growth phases. Headspace volatile molecules from culture supernatants were concentrated using solid-phase microextraction (SPME) and analysed via GC×GC-TOFMS. Ninety-two K. pneumoniae-associated volatile molecules were detected, of which 78 (85%) were detected at both phases of growth and 14 (15%) were detected at either mid-exponential or stationary growth phases.
CONCLUSIONS: This study has increased the total number of reported K. pneumoniae-associated volatile molecules from 77 to 150, demonstrating the sensitivity and resolution achieved by employing GC×GC-TOFMS for the analysis of bacterial headspace volatiles. SIGNIFICANCE AND IMPACT OF THE STUDY: This study represents an early-stage comprehensive volatile metabolomic analysis of an opportunistic bacterial pathogen. Characterizing the volatile molecules produced by K. pneumoniae during in vitro growth could provide us with a better understanding of this organisms' metabolism, an area that has not been extensively studied to date.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Klebsiella pneumoniaezzm321990; comprehensive two-dimensional gas chromatography; headspace analysis; mass spectrometry; metabolomics; volatile molecules

Mesh:

Substances:

Year:  2017        PMID: 27930839     DOI: 10.1111/jam.13372

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

1.  Comprehensive volatile metabolic fingerprinting of bacterial and fungal pathogen groups.

Authors:  Christiaan A Rees; Alison Burklund; Pierre-Hugues Stefanuto; Joseph D Schwartzman; Jane E Hill
Journal:  J Breath Res       Date:  2018-01-03       Impact factor: 3.262

2.  Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.

Authors:  Christiaan A Rees; Pierre-Hugues Stefanuto; Sarah R Beattie; Katherine M Bultman; Robert A Cramer; Jane E Hill
Journal:  J Breath Res       Date:  2017-08-21       Impact factor: 3.262

3.  Identification of metabolite extraction method for targeted exploration of antimicrobial resistance associated metabolites of Klebsiella pneumoniae.

Authors:  Ashok Kumar; Sevaram Singh; Sonu Kumar Gupta; Shailesh Kumar; Shrikant Kumar; Rita Singh; Lovnish Thakur; Manoj Kumar; Arti Kapil; Yashwant Kumar; Niraj Kumar
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

4.  SPME-GC×GC-TOF MS fingerprint of virally-infected cell culture: Sample preparation optimization and data processing evaluation.

Authors:  Giorgia Purcaro; Pierre-Hugues Stefanuto; Flavio A Franchina; Marco Beccaria; Wendy F Wieland-Alter; Peter F Wright; Jane E Hill
Journal:  Anal Chim Acta       Date:  2018-03-30       Impact factor: 6.558

5.  Volatile metabolic diversity of Klebsiella pneumoniae in nutrient-replete conditions.

Authors:  Christiaan A Rees; Katherine V Nordick; Flavio A Franchina; Alexa E Lewis; Elizabeth B Hirsch; Jane E Hill
Journal:  Metabolomics       Date:  2017-01-12       Impact factor: 4.290

6.  Impact of meropenem on Klebsiella pneumoniae metabolism.

Authors:  Claudio Foschi; Melissa Salvo; Luca Laghi; Chenglin Zhu; Simone Ambretti; Antonella Marangoni; Maria Carla Re
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

7.  Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles.

Authors:  Christiaan A Rees; Mavra Nasir; Agnieszka Smolinska; Alexa E Lewis; Katherine R Kane; Shannon E Kossmann; Orkan Sezer; Paola C Zucchi; Yohei Doi; Elizabeth B Hirsch; Jane E Hill
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.